
Icma 500mg/500mg Injection
Marketer
Eustoma Laboratories Pvt Ltd
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview Icma 500mg/500mg Injection
Combiflox 500mg/500mg Injection, a dual-antibiotic formulation, combats severe bacterial infections. Administered only under medical supervision, this medication requires adherence to the prescribed schedule; complete the entire course regardless of symptom improvement. Typical side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site reactions (redness, swelling, pain), typically resolving spontaneously. Severe side effects or allergic reactions (rash, itching, swelling, respiratory distress) necessitate immediate medical attention. Inform your physician of all current medications, and pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs.
Uses of Icma 500mg/500mg Injection
Life-threatening bacterial infections
Major Benefits of Icma 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Icma 500mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Icma 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Icma 500mg/500mg Injection works:
Icma Injection, containing 500mg of each Imipenem and Cilastatin, utilizes a dual-drug approach to combat bacterial infection. Imipenem, a potent antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial survival. Cilastatin, an inhibitor of dehydropeptidase I, prevents the enzymatic degradation of Imipenem. This protective action ensures sustained Imipenem efficacy within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Icma 500mg/500mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Icma 500mg/500mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Icma 500mg/500mg Injection while breastfeeding appears to be unlikely to cause harm. Available data from human studies indicate minimal risk to the infant.
DrivingUNSAFE
Administering Icma 500mg/500mg Injection may induce adverse reactions impacting driving capabilities. Certain side effects, including hallucinations (visual, auditory, or sensory), can impair some patients' ability to operate a vehicle.
KidneyCAUTION
The 500mg/500mg Icma injection requires careful administration for individuals with impaired renal function. Dosage modification for this injection may be necessary. A physician's consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Icma 500mg/500mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Icma 500mg/500mg Injection :
Should you forget to take a scheduled dose of Icma 500mg/500mg Injection, seek advice from your physician.
Facts to Know About Icma 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
